HLB Therapeutics Co (XKRX:115450) COGS-to-Revenue : 0.83 (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co COGS-to-Revenue?

HLB Therapeutics Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ₩10,573 Mil. Its Revenue for the three months ended in Mar. 2024 was ₩12,755 Mil.

HLB Therapeutics Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.83.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. HLB Therapeutics Co's Gross Margin % for the three months ended in Mar. 2024 was 17.10%.

HLB Therapeutics Co COGS-to-Revenue Historical Data

The historical data trend for HLB Therapeutics Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co COGS-to-Revenue Chart

HLB Therapeutics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.91

0.85

0.88

0.79

0.86

HLB Therapeutics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.88	0.85	0.85	0.88	0.83

HLB Therapeutics Co COGS-to-Revenue Calculation

HLB Therapeutics Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	46282.82	/	53749.063
	=	0.86

HLB Therapeutics Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	10573.406	/	12754.816
	=	0.83

HLB Therapeutics Co (XKRX:115450) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

HLB Therapeutics Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	10573.406 / 12754.816
	=	17.10 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

HLB Therapeutics Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of HLB Therapeutics Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Therapeutics Co (XKRX:115450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811

Website

https://www.hlbtherapeutics.co.kr

HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co (XKRX:115450) Headlines

No Headlines